Drug Trial Radar · NCT05483868
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Last checked: Nov 19, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
55
Planned (sponsor's estimate)
Start
Sep 26, 2022
Primary completion
Mar 2027
Study completion Mar 2027
Sponsor
- Lead sponsor
- Aura BiosciencesIndustry
- Sponsor type
- Industry
- First posted
- Aug 2, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objectives of this study are to determine the feasibility and safety of Belzupacap Sarotalocan (AU-011, bel-sar) treatment of bladder cancer utilizing focal injections with or without laser application.
Conditions
- Non-muscle-invasive Bladder Cancer
- NMIBC
- Non-Muscle Invasive Bladder Carcinoma
- Non-Muscle Invasive Bladder Neoplasms
- Non-Muscle Invasive Bladder Urothelial Carcinoma
- Urothelial Carcinoma Bladder
Interventions
AU-011Drug
Administration of AU-011 intratumorally and intramurally
AU-011 in Combination with Medical Laser AdminstrationCombination product
AU-011 Intratumorally and Intramurally
AU-011 in Combination with Medical Laser AdministrationCombination product
AU-011 Intratumorally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of AU-011: Incidences of SAEs and DLTsTime frame: up to 12 months
Locations
19 sites in 2 countries. Site status is shown where the registry gives one.
Arkansas Urology
Little Rock, Arkansas
Tower Urology
Los Angeles, California
Saint John's Cancer Institute
Santa Monica, California
Colorado Clinical Research
Lakewood, Colorado
Montefiore Medical Center
The Bronx, New York
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania
Carolina Urologic Research Center
Myrtle Beach, South Carolina
Urology Associates, P.C.
Nashville, Tennessee
Urology Clinics of North Texas
Dallas, Texas
Baylor College of Medicine
Houston, Texas
The University of Texas San Antonio
San Antonio, Texas
Urology San Antonio/USA Clinical Trials
San Antonio, Texas
The Urology Place
San Antonio, Texas
Westmead Private Hospital
Westmead, New South Wales, Australia
Austin Health
Heidelberg, Victoria, Australia
Warringal Private Hospital
Heidelberg, Victoria, Australia
Penninsula Private Hospital
Langwarrin, Victoria, Australia
The Royal Melbourne Hospital
Parkville, Victoria, Australia
Hollywood Private Hospital
Nedlands, Western Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.